Insider Buying

Cosmos Health Inc. (COSM) Insider Buying

Every C-suite and executive open-market purchase of Cosmos Health Inc. stock we've tracked from SEC Form 4 filings — each scored on our six-factor model. Not financial advice.

Tracked buys
12
Total value
$1,227,000
Most recent
Jun 16, 2026
Ticker Insider Role Value Filed Signal Score
COSM Cosmos Health Inc. Terzis Georgios Chief Financial Officer $42,000 Jun 17, 2026 WATCH 41
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $45,000 Jun 12, 2026 WATCH 56
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $160,000 Jun 12, 2026 WATCH 54
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $145,000 Feb 13, 2026 WATCH 50
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $120,000 Feb 12, 2026 WATCH 48
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $45,000 Jan 26, 2026 AVOID 39
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $175,000 Jan 21, 2026 AVOID 39
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $220,000 Jan 15, 2026 WATCH 44
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $57,000 Jan 13, 2026 AVOID 37
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $81,000 Jan 9, 2026 WATCH 42
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $65,000 Jan 8, 2026 WATCH 52
COSM Cosmos Health Inc. Siokas Grigorios Chief Executive Officer $72,000 Jan 7, 2026 AVOID 41

What this page tracks

This is a live record of open-market stock purchases by directors and officers of Cosmos Health Inc., sourced directly from SEC EDGAR Form 4 filings. We only count open-market buys — not option exercises or grants — because a personal-money purchase is the cleanest insider conviction signal.

Each filing is scored with our six-factor methodology (fundamentals, financials, technicals, conviction, CEO history, and cluster activity). See how the resulting signals performed against the S&P 500 on the track record, or browse this week's insider buys and the full signal screener.

Not financial advice. For educational purposes only. Form 4 data can be amended or filed late; analysis is generated using AI and may contain errors. Always do your own due diligence.